Dr Michael D West | CEO
BioTime, Inc.

Dr Michael D West, CEO, BioTime, Inc.

Dr. West is the Chief Executive Officer of BioTime, Inc. (NYSE-MKT: BTX) and its subsidiaries OrthoCyte Corporation and ReCyte Therapeutics. BioTime’s subsidiaries are focused on developing an array of research and therapeutic products using human embryonic stem cell technology. BioTime and its subsidiaries currently have three clinical trials underway in the field of regenerative medicine. He received his Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular aging.  He has focused his academic and business career on the application of developmental biology to the age-related degenerative disease.  He was the Founder of Geron Corporation of Menlo Park, California (Nasdaq: GERN) and from 1990 to 1998 he was a Director, and Vice President, where he initiated and managed programs in telomerase diagnostics, oligonucleotide-based telomerase inhibition as anti-tumor therapy, and the cloning and use of telomerase in telomerase-mediated therapy wherein telomerase is utilized to immortalize human cells.  From 1995 to 1998 he organized and managed the research collaboration between Geron and its academic collaborators James Thomson and John Gearhart that led to the first isolation of human embryonic stem and human embryonic germ cells. 

From 1998 to 2005 Dr. West was Chief Executive Officer and from 2005-2007 President and Chief Scientific Officer at Ocata Therapeutics (Nasdaq: OCAT) (previously known as Advanced Cell Technology) where he managed programs in somatic cell nuclear transfer, human embryonic stem cell-derived retinal pigment epithelial cell differentiation and product development, and PureStem, a technology for the multiplex derivation and characterization of clonal human embryonic progenitor cell lines.

In 2013 Dr. West led BioTime’s effort to acquire the pluripotent stem cell assets of Geron in Asterias Biotherapeutics (NYSE MKT: AST), currently a subsidiary of BioTime.

Dr. West is an inventor of over 200 patents and patent applications worldwide in the fields of molecular gerontology and regenerative medicine, and author of over 60 peer-reviewed scientific publications. Dr. West’s complete CV is available online at www.michaelwest.org

back to speakers

World Advanced Therapies & Regenerative Medicine Congress


Erica Baeta
+44 (0)207 092 1152


Jessica Robinson
t/ +44 (0)207 092 1150


Issa Mauthoor
+44 (0)207 092 1257